Fighting The New Coronavirus
Gilead publishes Remdesivir's first clinical study: 36 of 53 severe patients improved
Gilead published the first clinical research results of Remdesivir in the treatment of new coronavirus pneumonia (COVID-19) in the New England Medicine magazine.
3D simulation shows how coronavirus spreads in supermarkets
Researchers in Finland have developed a computer model that shows how viruses move and spread in the air, thus illustrating the importance of avoiding crowded areas.
Ultimate explanation: What is a coronavirus? How should humans fight it?
Professor Jin Dongyan, a molecular virologist from the University of Hong Kong's Li Ka Shing Faculty of Medicine, shared the theme of "The Past and Present of Human Coronavirus" online today.
Chinese scientists find 3D structure of new coronavirus's main protease
Chinese scientists recently published an article titled "Structure of Mpro from COVID-19 virus and discovery of its inhibitors" on Nature, taking the lead in successfully analyzing the high-resolution three-dimensional space of the main protease (Mpro), a key drug target of the new coronavirus, structure.
Crispr technology is used against new coronavirus
Stanford University scientists are actively exploring whether gene editing technology can be used to fight epidemics, but so far, they have only solved a small part of the mystery.
New coronavirus: detailed explanation of asymptomatic infections
Recently, people with asymptomatic infection with the new coronavirus pneumonia have attracted widespread attention, and many people may even get nervous.
Protective coating made of new materials may kill new coronavirus
At present, masks that protect doctors and nurses from new coronavirus infections can only play a protective role, but researchers from the University of Florida are developing a protective coating, which includes a new mask material, which can be used in several Stop and kill the virus in seconds.
World's first new coronavirus vaccine starts Phase II clinical trial
China-based CanSino Biologics announced on April 9 that its recombinant new coronavirus vaccine (adenoviral vector) is planning to conduct a phase II clinical trial in China in the near future based on preliminary safety data from the phase I clinical trial.
Chinese scholar develops rapid detection system for coronavirus nucleic acid
A team led by researcher Wang Daming of Suzhou Institute of Biomedical Engineering Technology, Chinese Academy of Sciences has recently developed a new rapid detection system for coronavirus nucleic acid.
New antiviral drug provides hope in fight against coronavirus
A new drug called EIDD-2801 is expected to change the way doctors treat new coronary pneumonia. The drug can reduce lung damage in animal tests and is about to enter human clinical trials.